-
2024-513077-48-00
5
2024-12-19
O6-methylguanine methyltransferase (MGMT) unmethylated glioblastoma
-
2023-510422-32-00
5
2024-09-10
Tenosynovial Giant Cell Tumour
-
2023-509566-38-00
9
2024-08-05
gastroesophageal junction adenocarcinoma
-
2023-510275-64-00
9
2023-05-31
Hepatocellular carcinoma, colorectal cancer, endometrial
cancer, or ot
-
2023-509335-60-00
1
2023-02-23
Advanced solid tumors including (but not limited to), non-small cell l
-
2024-520238-31-01
9
2026-04-20
Advanced Lung Cancer
-
2025-524542-10-00
4
2026-04-14
Endometrial cancer
-
2024-519208-29-00
4
2026-04-02
Pleural mesothelioma
-
2025-523224-45-00
10
2026-03-30
Untreated, Unresectable or Metastatic Colorectal Cancer
-
2024-517979-20-00
9
2026-03-04
Advanced Breast Cancer
Metastatic Breast Cancer
-
2025-521124-29-00
10
2026-02-13
Non-Small Cell Lung Cancer
-
2025-522139-33-00
7
2026-02-10
Advanced or metastatic solid tumours
-
2024-515948-23-00
5
2026-02-06
Advanced pulmonary or gastroenteropancreatic poorly differentiated neu
-
2025-522151-26-00
5
2026-02-06
Advanced or Metastatic Non-Small-Cell Lung Cancer With Epidermal Growt
-
2024-515765-34-00
5
2026-02-04
English
First-line extensive-stage small-cell lung cancer (ES-SCLC)
-
2025-521627-78-00
5
2026-01-28
Neoplasms, Lung
-
2024-515023-11-00
5
2026-01-22
Metastatic Clear Cell Renal Cell Carcinoma
-
2025-521917-24-00
5
2026-01-21
Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
-
2024-513619-28-00
1
2025-12-11
Clear Cell Renal Cell Carcinoma
-
2024-513586-39-00
5
2025-12-10
Prostate Cancer
-
2025-520730-28-00
4
2025-12-08
Common EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung
-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2024-519971-25-00
5
2025-12-03
Advanced MET exon 14 Mutated Non-Small Cell Lung Cancer
-
2024-517658-90-00
3
2025-12-01
triple-negative breast cancer